RE:Zero newsIf Quest Pharmatech Inc's ("QPT") survival depends on them borrowing a million dollars to stay alive, from OncoQuest Inc, rather than generating income on their own this does not bode well for QPT shareholders. They will simply keep on borrowing against future possible payments from OncoQuest Inc. Just to note that OncoQuest Inc had received US$8,387,503 in cash from OQP, as stated in the Jan 5, 2021, Asset Transfer Update / Newswire.
Trust that Dr. Madiyalakan, CEO of Quest and OncoQuest and Chairman of OQP, protects our interests going forward. Our fate rests solely in his hands.
GLTA
G1945V